Telephone
61.3.9547.1888
Address
Factory 6 4 Caribbean Drive Scoresby, Victoria (VIC) 3179
Description
Medical Developments International Ltd. engages in the manufacture and distribution of pharmaceutical drugs, medical, and veterinary equipment. It operates through the following segments: Pharmaceuticals, Medical Equipment, and Veterinary Equipment. The Pharmaceuticals segment involves the selling of Penthrox drugs. The Medical Equipment segment includes the sale of medical devices. The Veterinary Equipment segment relates to the sale of veterinary products within Australia, Europe, and Asia. The company was founded in 1971 and is headquartered in Scoresby, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.7 - 1.85
Trade Value (12mth)
AU$36,848.00
1 week
-1.95%
1 month
-6.21%
YTD
-49.33%
1 year
-52.81%
All time high
11.593
EPS 3 yr Growth
-1268.400%
EBITDA Margin
-53.10%
Operating Cashflow
-$16m
Free Cash Flow Return
-23.00%
ROIC
-7.80%
Interest Coverage
-180.60
Quick Ratio
2.20
Shares on Issue (Fully Dilluted)
86m
HALO Sector
Healthcare
Next Company Report Date
22-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.68
Date | Announcements |
---|---|
31 October 23 |
2023 Annual General Meeting Recording
×
2023 Annual General Meeting Recording |
31 August 23 |
FY23 Full Year Accounts
×
FY23 Full Year Accounts |
31 August 23 |
MVP Announces FY23 Full Year Results
×
MVP Announces FY23 Full Year Results |
31 August 23 |
FY23 Full Year Results Investor Presentation
×
FY23 Full Year Results Investor Presentation |
31 August 23 |
Appointment of Director - Dr Russell Basser
×
Appointment of Director - Dr Russell Basser |
31 August 23 |
Initial Director's Interest Notice
×
Initial Director's Interest Notice |
31 August 23 |
Changes to CEO Remuneration and Employment Contract
×
Changes to CEO Remuneration and Employment Contract |
31 August 22 |
Application for Quotation of Securities
×
Application for Quotation of Securities |
30 October 19 |
CEO Roadshow Presentation
×
CEO Roadshow Presentation |
30 May 22 |
Appointment of General Counsel and Company Secretary
×
Appointment of General Counsel and Company Secretary |
30 May 16 |
CEO US Roadshow Presentation
×
CEO US Roadshow Presentation |
30 June 20 |
MVP Roadshow Presentation
×
MVP Roadshow Presentation |
30 August 22 |
Completion of Retail Entitlement Offer
×
Completion of Retail Entitlement Offer |
29 September 06 |
Notice of Annual General Meeting
×
Notice of Annual General Meeting |
29 September 06 |
Annual Report 2006
×
Annual Report 2006 |
28 September 07 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
28 September 07 |
Annual Report 2007
×
Annual Report 2007 |
28 October 22 |
Annual General Meeting - Recording available
×
Annual General Meeting - Recording available |
28 October 14 |
2014 AGM Presentation
×
2014 AGM Presentation |
28 November 23 |
Notification of cessation of securities - MVP
×
Notification of cessation of securities - MVP |
28 November 23 |
Notification regarding unquoted securities - MVP
×
Notification regarding unquoted securities - MVP |
28 August 23 |
Ceasing to be a substantial holder for MVP
×
Ceasing to be a substantial holder for MVP |
27 October 23 |
2023 Annual General Meeting Presentation
×
2023 Annual General Meeting Presentation |
27 October 23 |
2023 Annual General Meeting Chair and CEO address
×
2023 Annual General Meeting Chair and CEO address |
27 October 23 |
Results of Annual General Meeting
×
Results of Annual General Meeting |
27 October 22 |
Chair and CEO Address to Shareholders
×
Chair and CEO Address to Shareholders |
27 October 22 |
Chair and CEO Presentation to Shareholders
×
Chair and CEO Presentation to Shareholders |
27 October 22 |
Final Director's Interest Notice - M. Johnston
×
Final Director's Interest Notice - M. Johnston |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.